First Horizon Advisors, Inc. - Novozymes A/S ownership

Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 14 filers reported holding Novozymes A/S in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
First Horizon Advisors, Inc. ownership history of Novozymes A/S
ValueSharesWeighting
Q3 2021$3,0000.0%470.0%0.00%
Q2 2021$3,0000.0%470.0%0.00%
Q1 2021$3,000
-50.0%
47
-62.1%
0.00%
-100.0%
Q1 2018$6,0000.0%1240.0%0.00%0.0%
Q4 2017$6,0000.0%1240.0%0.00%0.0%
Q3 2017$6,000
+20.0%
1240.0%0.00%0.0%
Q2 2017$5,0000.0%1240.0%0.00%0.0%
Q1 2017$5,000
-16.7%
124
-21.5%
0.00%0.0%
Q4 2016$6,0000.0%1580.0%0.00%0.0%
Q3 2016$6,0000.0%158
+19.7%
0.00%0.0%
Q2 2016$6,0001320.00%
Other shareholders
Novozymes A/S shareholders Q1 2021
NameSharesValueWeighting ↓
Lenox Wealth Management, Inc. 62,488$2,907,0000.87%
ZEVIN ASSET MANAGEMENT LLC 34,899$1,624,0000.52%
HIGH POINTE CAPITAL MANAGEMENT LLC 5,090$238,0000.33%
BOSTON FINANCIAL MANGEMENT LLC 108,846$5,065,0000.29%
Moloney Securities Asset Management, LLC 15,263$713,0000.24%
Boston Common Asset Management, LLC 24,577$1,148,0000.14%
Hemenway Trust Co LLC 12,125$564,0000.09%
Renaissance Investment Group LLC 5,000$234,0000.09%
QUADRANT CAPITAL GROUP LLC 5,748$263,0000.04%
Douglass Winthrop Advisors, LLC 6,902$321,0000.01%
View complete list of Novozymes A/S shareholders